Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 1
2012 1
2013 1
2014 1
2015 2
2016 5
2017 5
2018 5
2019 5
2020 3
2021 6
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma.
Bharathan R, Polterauer S, Lopez-Sanclemente MC, Trukhan H, Pletnev A, Heredia AG, Gil MM, Bakinovskaya I, Dalamanava A, Romeo M, Rovski D, Baquedano L, Chiva L, Schwameis R, Zapardiel I, On Behalf Of Sarcut Study Group. Bharathan R, et al. Among authors: schwameis r. J Pers Med. 2024 Jan 30;14(2):155. doi: 10.3390/jpm14020155. J Pers Med. 2024. PMID: 38392588 Free PMC article.
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres.
Schwameis R, Fanfani F, Ebner C, Zimmermann N, Peters I, Nero C, Marth C, Ristl R, Leitner K, Grimm C, Oberndorfer F, Capasso I, Zeimet AG, Polterauer S, Scambia G, Fagotti A, Concin N. Schwameis R, et al. Eur J Cancer. 2023 Nov;193:113317. doi: 10.1016/j.ejca.2023.113317. Epub 2023 Sep 1. Eur J Cancer. 2023. PMID: 37748967 Free article.
An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app.
Gaillard T, Schwameis R, Laas-Faron E, Eisenberg-Nissim T, Matias-Guiu X, Creutzberg CL, Ledermann J, Planchamp F, Concin N. Gaillard T, et al. Among authors: schwameis r. Int J Gynecol Cancer. 2023 Aug 7;33(8):1181-1184. doi: 10.1136/ijgc-2023-004598. Int J Gynecol Cancer. 2023. PMID: 37460218
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer.
Harter P, Bogner G, Chiva L, Cibula D, Concin N, Fotopoulou C, Gonzalez-Martin A, Guyon F, Heinzelmann-Schwarz V, Kridelka F, Mahner S, Marmé F, Marth C, Morice P, Novák Z, Papadia A, Ray-Coquard I, Redecha M, Redondo A, Schwameis R, Sehouli J, Undurraga M, Van Gorp T, Vergote I. Harter P, et al. Among authors: schwameis r. Bull Cancer. 2024 Mar;111(3):277-284. doi: 10.1016/j.bulcan.2023.02.011. Epub 2023 Mar 24. Bull Cancer. 2024. PMID: 36967330 Review.
The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer.
Yazdian M, Groeben H, Ataseven B, Schneider S, Baert T, Bommert M, Traut A, Elfers-Wassenhoven A, Brüß U, Schwameis R, du Bois A, Wagner U, Harter P. Yazdian M, et al. Among authors: schwameis r. Arch Gynecol Obstet. 2022 May;305(5):1311-1318. doi: 10.1007/s00404-021-06308-z. Epub 2021 Nov 1. Arch Gynecol Obstet. 2022. PMID: 34724570
42 results